Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2008 1
2009 2
2010 3
2011 2
2014 2
2015 6
2016 11
2017 3
2018 1
2019 3
2020 6
2021 14
2022 16
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy.
Ruigrok EAM, van Vliet N, Dalm SU, de Blois E, van Gent DC, Haeck J, de Ridder C, Stuurman D, Konijnenberg MW, van Weerden WM, de Jong M, Nonnekens J. Ruigrok EAM, et al. Among authors: konijnenberg mw. Eur J Nucl Med Mol Imaging. 2021 May;48(5):1339-1350. doi: 10.1007/s00259-020-05057-6. Epub 2020 Oct 23. Eur J Nucl Med Mol Imaging. 2021. PMID: 33094433 Free PMC article.
Urinary excretion kinetics of [177Lu]Lu-PSMA-617.
de Bakker M, Dominicus N, Meeuwis A, Janssen M, Konijnenberg MW, Nagarajah J, Peters SMB. de Bakker M, et al. Among authors: konijnenberg mw. Eur J Nucl Med Mol Imaging. 2023 Oct;50(12):3572-3575. doi: 10.1007/s00259-023-06328-8. Epub 2023 Jul 8. Eur J Nucl Med Mol Imaging. 2023. PMID: 37421427 Free PMC article.
In vitro dose effect relationships of actinium-225- and lutetium-177-labeled PSMA-I&T.
Ruigrok EAM, Tamborino G, de Blois E, Roobol SJ, Verkaik N, De Saint-Hubert M, Konijnenberg MW, van Weerden WM, de Jong M, Nonnekens J. Ruigrok EAM, et al. Among authors: konijnenberg mw. Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3627-3638. doi: 10.1007/s00259-022-05821-w. Epub 2022 May 12. Eur J Nucl Med Mol Imaging. 2022. PMID: 35556158 Free PMC article.
How to attract young talent to nuclear medicine step 1: a survey conducted by the EANM Oncology and Theranostics Committee to understand the expectations of the next generation.
Ambrosini V, Carrilho Vaz S, Ahmadi Bidakhvidi N, Chanchou M, Cysouw MCF, Serani F, Voltin CA, Kraeber-Bodere F, Deroose CM, De Geus-Oei LF, Eiber M, Gnanasegaran G, Gotthardt M, Kobe C, Konijnenberg MW, Nanni C, Oprea Lager DE, Rahbar K, Taieb D, Mottaghy FM, Goffin K, Herrmann K. Ambrosini V, et al. Among authors: konijnenberg mw. Eur J Nucl Med Mol Imaging. 2023 Dec;51(1):3-11. doi: 10.1007/s00259-023-06389-9. Eur J Nucl Med Mol Imaging. 2023. PMID: 37689611 Free PMC article. No abstract available.
Preclinical animal research on therapy dosimetry with dual isotopes.
Konijnenberg MW, de Jong M. Konijnenberg MW, et al. Eur J Nucl Med Mol Imaging. 2011 May;38 Suppl 1(Suppl 1):S19-27. doi: 10.1007/s00259-011-1774-4. Epub 2011 Apr 1. Eur J Nucl Med Mol Imaging. 2011. PMID: 21484379 Free PMC article. Review.
Nephrotoxicity after PRRT with (177)Lu-DOTA-octreotate.
Bergsma H, Konijnenberg MW, van der Zwan WA, Kam BL, Teunissen JJ, Kooij PP, Mauff KA, Krenning EP, Kwekkeboom DJ. Bergsma H, et al. Among authors: konijnenberg mw. Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1802-11. doi: 10.1007/s00259-016-3382-9. Epub 2016 May 10. Eur J Nucl Med Mol Imaging. 2016. PMID: 27160225 Free PMC article.
Errare humanum est, sed in errare perseverare diabolicum: methodological errors in the assessment of the relationship between I-131 therapy and possible increases in the incidence of malignancies.
Verburg FA, Hoffmann M, Iakovou I, Konijnenberg MW, Mihailovic J, Gabina PM, Ovčariček PP, Reiners C, Vrachimis A, Zerdoud S, Giovanella L, Luster M. Verburg FA, et al. Among authors: konijnenberg mw. Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):519-522. doi: 10.1007/s00259-019-04580-5. Eur J Nucl Med Mol Imaging. 2020. PMID: 31807882 No abstract available.
I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth?
Verburg FA, Giovanella L, Iakovou I, Konijnenberg MW, Langsteger W, Lassmann M, Mihailovic J, Luster M. Verburg FA, et al. Among authors: konijnenberg mw. Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2247-2249. doi: 10.1007/s00259-018-4184-z. Epub 2018 Oct 8. Eur J Nucl Med Mol Imaging. 2018. PMID: 30298378 No abstract available.
69 results